Hemas Holdings
Gesundheits- und Körperpflegekonzern in Colombo mit regionalem Pharmavertrieb.
Hemas Holdings ist ein srilankischer Mischkonzern mit den Geschäftsbereichen Gesundheitswesen und Konsumgüter. Der 1948 gegründete FMCG-Zweig produziert Körperpflegeprodukte (Baby Cheramy, Clogard) und sein Gesundheitszweig vertreibt Arzneimittel in ganz Süd- und Südostasien.
- Type
- brand seeking distribution
- Location
- Colombo, Sri Lanka
- Founded
- 1948
- Website
- hemas.com
- Categories
- Medizin- & Gesundheitsbedarf, Körperpflege
- Markets
- Bangladesch, Pakistan, Malaysia, Vereinigte Arabische Emirate
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
- lei-lapsed (amber), checked 2026-08-30 GLEIF global LEI register (golden copy)
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
Import rules for these goods
- Cosmetic products must be notified in the EU Cosmetic Products Notification Portal (CPNP) before being placed on the EU market. European Commission (CPNP)
- For the US market, MoCRA requires cosmetic facility registration and product listing with the FDA. US FDA (MoCRA)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)